Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2018

01-07-2018 | Original Article

Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures

Authors: Siti Salmah Noordin, Faraizah Abdul Karim, Wan Mohd Zahiruddin bin Wan Mohammad, Abdul Rahim Hussein

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2018

Login to get access

Abstract

Thawed plasma is fresh frozen plasma (FFP) that has been stored for 5 days at 1–6 °C. Duration of storage and different storage temperatures might affect the coagulation factor activity in thawed FFP. This study measured the changes of coagulation factor activities over 5 days in thawed FFP and stored at two different initial storage temperatures. Thirty-six units of FFP, which consisted of nine units each from blood groups A, B, AB, and O, were thawed at 37 °C. Each unit was divided into two separate groups (Group A and Group B) based on initial storage temperature. The first group was stored at 2–6 °C for 5 days (Group A). The second group was stored at 20–24 °C for initial 6 h followed by 2–6 °C for 5 days (Group B). Prothrombin time (PT), activated partial thromboplastin time (APTT), coagulation factor activities of fibrinogen, factor (F) II, FV, FVII, FVIII, FIX, FX, and von Willebrand factor antigen (vWF Ag) were assessed at baseline after thawing, at 6 h, and on days 1, 3, and 5 of storage for both groups. All coagulation factors mean activities in both storage groups decreased significantly over 5 days of storage. The mean FVIII activity at day 5 of storage was 36.9% in Group A and 39.8% in Group B. The other coagulation factors mean activities were > 50% on day 5 of storage in both groups. The coagulation factor activities of thawed FFP stored for 5 consecutive days were reduced in the two storage groups but most of the activities were still above 30%. This study suggests that thawed FFP stored for 5 days has the potential to ameliorate coagulation factor deficiencies in affected patients.
Literature
1.
go back to reference Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF et al (2011) The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 51(1):62–70CrossRefPubMed Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF et al (2011) The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 51(1):62–70CrossRefPubMed
2.
go back to reference Kakaiya R, Aronson C J J. (2011) Technical Manual AABB. In: Roback J, Grossman B, Harris T, Hillyer C, 17th edn. American Association of Blood Banks p. 187–226 Kakaiya R, Aronson C J J. (2011) Technical Manual AABB. In: Roback J, Grossman B, Harris T, Hillyer C, 17th edn. American Association of Blood Banks p. 187–226
3.
go back to reference Yazer MH (2012) A primer on evidence-based plasma therapy. ISBT Sci Ser 7(1):220–225CrossRef Yazer MH (2012) A primer on evidence-based plasma therapy. ISBT Sci Ser 7(1):220–225CrossRef
4.
go back to reference Downes KA, Wilson E, Yomtovian R, Sarode R (2001) Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 41(4):570CrossRefPubMed Downes KA, Wilson E, Yomtovian R, Sarode R (2001) Serial measurement of clotting factors in thawed plasma stored for 5 days. Transfusion 41(4):570CrossRefPubMed
5.
go back to reference Eder AF, Sebok MA (2007) Plasma components: FFP, FP24, and thawed plasma. Immunohematology 23(4):150–157PubMed Eder AF, Sebok MA (2007) Plasma components: FFP, FP24, and thawed plasma. Immunohematology 23(4):150–157PubMed
6.
go back to reference Australian and New Zealand Society of Blood Transfusion (2013) Extended life plasma: A framework for preparation, storage and use, 2nd edn. Australian and New Zealand Society of Blood Transfusion Ltd, Sydney Australian and New Zealand Society of Blood Transfusion (2013) Extended life plasma: A framework for preparation, storage and use, 2nd edn. Australian and New Zealand Society of Blood Transfusion Ltd, Sydney
7.
go back to reference Scott E, Puca K, Heraly J, Gottschall J, Friedman K (2009) Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6 °C storage. Transfusion 49(8):1584–1591CrossRefPubMed Scott E, Puca K, Heraly J, Gottschall J, Friedman K (2009) Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6 °C storage. Transfusion 49(8):1584–1591CrossRefPubMed
8.
go back to reference Wang Z, Du X, Li C, Ma L, Sun P, Cao H et al (2014) Coagulation factors and inhibitors in thawed plasma stored at 1–6 °C for 5 days in China. Transfus Apher Sci 50(2):274–280CrossRefPubMed Wang Z, Du X, Li C, Ma L, Sun P, Cao H et al (2014) Coagulation factors and inhibitors in thawed plasma stored at 1–6 °C for 5 days in China. Transfus Apher Sci 50(2):274–280CrossRefPubMed
9.
go back to reference National Blood Centre (2016) Ministry of Health Malaysia. Transfusion Practice Guidelines for Clinical and Laboratory Personnel. 4th ed National Blood Centre (2016) Ministry of Health Malaysia. Transfusion Practice Guidelines for Clinical and Laboratory Personnel. 4th ed
10.
go back to reference Nascimento B, Callum J, Rubenfeld G, Neto JBR, Lin Y, Rizoli S (2010) Clinical review: Fresh frozen plasma in massive bleedings–more questions than answers. Crit Care 14(1):202CrossRefPubMedPubMedCentral Nascimento B, Callum J, Rubenfeld G, Neto JBR, Lin Y, Rizoli S (2010) Clinical review: Fresh frozen plasma in massive bleedings–more questions than answers. Crit Care 14(1):202CrossRefPubMedPubMedCentral
11.
go back to reference Wehrli G, Taylor NE, Haines AL, Brady TW, Mintz PD (2009) Instituting a thawed plasma procedure: it just makes sense and saves cents. Transfusion 49(12):2625–2630CrossRefPubMed Wehrli G, Taylor NE, Haines AL, Brady TW, Mintz PD (2009) Instituting a thawed plasma procedure: it just makes sense and saves cents. Transfusion 49(12):2625–2630CrossRefPubMed
12.
go back to reference Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE et al (2013) An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 148(2):170–175CrossRefPubMedPubMedCentral Radwan ZA, Bai Y, Matijevic N, del Junco DJ, McCarthy JJ, Wade CE et al (2013) An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 148(2):170–175CrossRefPubMedPubMedCentral
13.
go back to reference Holcomb JB, Donathan DP, Cotton BA, Del Junco DJ, Brown G, Wenckstern TV et al (2015) Prehospital Transfusion of Plasma and Red Blood Cells in Trauma Patients. Prehosp Emerg Care 19(1):1–9CrossRefPubMed Holcomb JB, Donathan DP, Cotton BA, Del Junco DJ, Brown G, Wenckstern TV et al (2015) Prehospital Transfusion of Plasma and Red Blood Cells in Trauma Patients. Prehosp Emerg Care 19(1):1–9CrossRefPubMed
14.
go back to reference von Heymann C, Keller MK, Spies C, Schuster M, Meinck K, Sander M et al (2009) Activity of clotting factors in fresh-frozen plasma during storage at 4 °C over 6 days. Transfusion 49(5):913–920CrossRef von Heymann C, Keller MK, Spies C, Schuster M, Meinck K, Sander M et al (2009) Activity of clotting factors in fresh-frozen plasma during storage at 4 °C over 6 days. Transfusion 49(5):913–920CrossRef
15.
16.
go back to reference Tholpady A, Monson J, Radovancevic R, Klein K, Bracey A (2013) Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days? Transfusion 53(3):645–650CrossRefPubMed Tholpady A, Monson J, Radovancevic R, Klein K, Bracey A (2013) Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days? Transfusion 53(3):645–650CrossRefPubMed
17.
go back to reference Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C (2012) Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to 5 days after thawing. Transfusion 52(3):493–502CrossRefPubMed Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C (2012) Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to 5 days after thawing. Transfusion 52(3):493–502CrossRefPubMed
18.
go back to reference Milam JD, Buzzurro CJ, Austin SF, Stansberry SW (1980) Stability of factors V and VIII in thawed fresh frozen plasma units. Transfusion 20(5):546–548CrossRefPubMed Milam JD, Buzzurro CJ, Austin SF, Stansberry SW (1980) Stability of factors V and VIII in thawed fresh frozen plasma units. Transfusion 20(5):546–548CrossRefPubMed
19.
go back to reference Sidhu RS, Le T, Brimhall B, Thompson H (2006) Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1–6 °C for 5 days. J Clin Apher 21(4):224–226CrossRefPubMed Sidhu RS, Le T, Brimhall B, Thompson H (2006) Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1–6 °C for 5 days. J Clin Apher 21(4):224–226CrossRefPubMed
20.
go back to reference Naghadeh HT, Maghsudloo M, Tabatabaei MR (2011) Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1–6 masculine C for 5 days. Blood Transfusion 9(1):95–98PubMedPubMedCentral Naghadeh HT, Maghsudloo M, Tabatabaei MR (2011) Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1–6 masculine C for 5 days. Blood Transfusion 9(1):95–98PubMedPubMedCentral
21.
go back to reference Pipe SW, Morris JA, Shah J, Kaufman RJ (1998) Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J Biol Chem 273(14):8537–8544CrossRefPubMed Pipe SW, Morris JA, Shah J, Kaufman RJ (1998) Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J Biol Chem 273(14):8537–8544CrossRefPubMed
22.
go back to reference Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thrombosis J 5:14CrossRef Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thrombosis J 5:14CrossRef
23.
go back to reference Yazer MH, Cortese-Hassett A, Triulzi DJ (2008) Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1–6 °C. Transfusion. 48(12):2525–2530CrossRefPubMed Yazer MH, Cortese-Hassett A, Triulzi DJ (2008) Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1–6 °C. Transfusion. 48(12):2525–2530CrossRefPubMed
24.
go back to reference Lamboo M, Poland DC, Eikenboom JC, Harvey MS, Groot E, Brand A et al (2007) Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures. Transfus Med 17(3):182–186CrossRefPubMed Lamboo M, Poland DC, Eikenboom JC, Harvey MS, Groot E, Brand A et al (2007) Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures. Transfus Med 17(3):182–186CrossRefPubMed
25.
go back to reference Engbers MJ, Cushman M, Rosendaal FR, Van Hylckama Vlieg A (2012) The effect of time between venipuncture, processing and freezing on the measurement of coagulation factor levels. J Thromb Haemost 10(8):1691–1693CrossRefPubMed Engbers MJ, Cushman M, Rosendaal FR, Van Hylckama Vlieg A (2012) The effect of time between venipuncture, processing and freezing on the measurement of coagulation factor levels. J Thromb Haemost 10(8):1691–1693CrossRefPubMed
26.
go back to reference Dzik WH, Riibner MA, Linehan SK (1989) Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C. Transfusion 29(7):600–604CrossRefPubMed Dzik WH, Riibner MA, Linehan SK (1989) Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C. Transfusion 29(7):600–604CrossRefPubMed
27.
go back to reference Ben-Tal O, Zwang E, Eichel R, Badalbev T, Hareuveni M (2003) Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion 43(7):873–877CrossRefPubMed Ben-Tal O, Zwang E, Eichel R, Badalbev T, Hareuveni M (2003) Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion 43(7):873–877CrossRefPubMed
28.
go back to reference Aggeler PM (1961) Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review. Transfusion 1(2):71–86CrossRefPubMed Aggeler PM (1961) Physiological basis for transfusion therapy in hemorrhagic disorders: a critical review. Transfusion 1(2):71–86CrossRefPubMed
Metadata
Title
Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures
Authors
Siti Salmah Noordin
Faraizah Abdul Karim
Wan Mohd Zahiruddin bin Wan Mohammad
Abdul Rahim Hussein
Publication date
01-07-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0879-8

Other articles of this Issue 3/2018

Indian Journal of Hematology and Blood Transfusion 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine